Ahmad, Shahzad http://orcid.org/0000-0002-8658-3790
Milan, Marta del Campo http://orcid.org/0000-0003-2808-3699
Hansson, Oskar http://orcid.org/0000-0001-8467-7286
Demirkan, Ayse
Agustin, Ruiz http://orcid.org/0000-0003-2633-2495
Sáez, Maria E. http://orcid.org/0000-0001-9299-2534
Giagtzoglou, Nikolaos
Cabrera-Socorro, Alfredo http://orcid.org/0000-0003-4991-763X
Bakker, Margot H. M.
Ramirez, Alfredo
Hankemeier, Thomas
Stomrud, Erik
Mattsson-Carlgren, Niklas http://orcid.org/0000-0002-8885-7724
Scheltens, Philip http://orcid.org/0000-0002-1046-6408
van der Flier, Wiesje M. http://orcid.org/0000-0001-8766-6224
Ikram, M. Arfan http://orcid.org/0000-0003-0372-8585
Malarstig, Anders http://orcid.org/0000-0003-2608-1358
Teunissen, Charlotte E. http://orcid.org/0000-0002-4061-0837
Amin, Najaf
van Duijn, Cornelia M. http://orcid.org/0000-0002-2374-9204
Article History
Received: 30 July 2019
Accepted: 24 April 2020
First Online: 19 May 2020
Competing interests
: S.A., M.C.M., A.D., R.A., M.E.S., A.R., T.H., E.S., N.M., P.S., M.A.I., N.A., C.M.D. declare no competing interests. O.H. has acquired research support (for the institution) from Roche, Pfizer, GE Healthcare, Biogen, AVID Radiopharmaceuticals and Euroimmun. In the past 2 years, O.H. has received consultancy/speaker fees (paid to the institution) from Biogen and Roche. Dr. Nikolaos Giagtzoglou was an employee at Biogen Idec, USA. Dr. Alfredo Cabrera-Socorro is an employee of Janssen Pharmaceutical NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Dr. Margot H.M. Bakker is a full time employee of AbbVie GmbH & Co KG and owns AbbVie stock. AbbVie contributed to the study design, research, and interpretation of data, reviewing, and approving the publication. Prof. dr. Teunissen has functioned in advisory boards of Roche, received non-financial support in the form of research consumables from ADxNeurosciences and Euroimmun, performed contract research or received grants from Probiodrug, Biogen, Esai, Toyama, Janssen prevention center, Boehringer, AxonNeurosciences, EIP farma, PeopleBio, Roche.Research programs of Prof. dr. Wiesje van der Flier have been funded by ZonMW, NWO, EU-FP7, Alzheimer Nederland, CardioVascular Onderzoek Nederland, stichting Dioraphte, Gieskes-Strijbis fonds, Pasman stichting, Biogen MA Inc, Boehringer Ingelheim, Piramal Neuroimaging, Roche BV, Janssen Stellar, Combinostics. WF holds the Pasman chair. WF has performed contract research for Biogen MA Inc and Boehringer Ingelheim. WF has been an invited speaker at Boehringer Ingelheim and Biogen MA Inc. All funding is paid to her institution.